P2RY13 and breast cancer: P2RY13 is a G-protein-coupled receptor, and it was reported to be decreased upon epidermal growth factor (EGF)- and hypoxia-induced epithelial–mesenchymal transition (EMT) in breast cancer cells (57, 58).